Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0530
0.00 (0.00%)
Oct 27, 2026, 1:20 PM AEDT
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 28.78 million as of October 27, 2026. It is the 36,805th most valuable company in the world and the 962nd biggest in Australia. Its market cap has increased by 144.51% in one year.
Market Cap
28.78M
Enterprise Value
27.25M
Revenue
4.77M
Global Rank
Country Rank
#962 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 28.78M, a decrease of -70.73%. That is a compound annual growth rate of -18.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 28.78M | 16.94% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyclopharm | 47.15M |
| HeraMED | 46.35M |
| Compumedics | 45.95M |
| Nova Eye Medical | 42.74M |
| Cleo Diagnostics | 41.82M |
| CleanSpace Holdings | 38.49M |
| Micro-X | 30.85M |
| OncoSil Medical | 25.69M |